Syntopia
Biotechnology Research • 
Paris, Île-de-France, France • 1-10 Employees
Company overview
| Headquarters | 6, Rue Jean Calvin, Institut Pierre-Gilles de Gennes, Paris, Île-de-France 75005, FR |
| NAICS | 541714 |
| Keywords | Drug Discovery, Oncology, Rare Diseases, High-Content Screening, Life Cycle Management, Microfluidic, High-Throughput Screening, 3D Cell Models, Deep Learning Neural Network, Phenotypic Analysis |
| Founded | 2024 |
| Employees | 1-10 |
Key Contact at Syntopia
Adrien Rennesson
Co-founder
About Syntopia
SYNTOPIA is developing innovative tools enabling the pharmaceutical industry and CROs to use patients' primary cells on a large-scale in their in vitro cell-based assays. Our techbio platform combines high-throughput phenotypic screening on a microfluidic chip and in silico models to predict the evolution of key parameters of a biological system (100 times more) from a minimum of experiments (10 times less), paving the way for a faster and less costly understanding of biological systems. SYNTOPIA is a Parisian startup and a spin-off from the Laboratory of Biophysics and Evolution at ESPCI-PSL University. Our development is supported by prestigious national and European programs and its core technology is protected by two patents.
Syntopia revenue & valuation
| Annual revenue | $171,110 |
| Revenue per employee | $86,000 |
| Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues | $547,552 |
| Total funding | No funding |
Employees by Management Level
Total employees: 1-10
Seniority
Employees
Employees by Department
Syntopia has 1 employees across 1 departments.
Departments
Number of employees
Funding Data
Syntopia has never raised funding before.
New Zealand
United States
Australia
Switzerland
United Kingdom
Frequently asked questions
4.8
40,000 users
